CORPORATE ANNOUNCEMENTChemicals - Specialty

Tanfac Industries Limited makes a corporate announcement

Tanfac Industries LimitedTANFACIND

TL;DR

Current AHF utilization is approximately 75% in Q1 FY27. This is below the 95% FY26 utilization reported after the expanded hydrofluoric acid capacity was commissioned, although the comparison is between a quarterly rate and a full-year rate.

With the recent completion of the Anhydrous Hydrofluoric Acid (AHF) capacity expansion, what is the current capacity utilization rate, and how does this align with the volume growth targets disclosed in the latest Annual Report?

Current AHF utilization is approximately 75% in Q1 FY27. This is below the 95% FY26 utilization reported after the expanded hydrofluoric acid capacity was commissioned, although the comparison is between a quarterly rate and a full-year rate. Management also referred to 73% for the broader HF plant in the same call; 75% is the AHF-specific figure. [1] [2]

Alignment with the Annual Report

  • The expansion increased HF capacity from approximately 14,850 TPA to around 30,000 TPA and was commissioned in October 2024. [3]
  • At 75% utilization, the business is operating below the FY26 near-full-utilization benchmark by approximately 20 percentage points, but still has meaningful headroom to ramp volumes. This should not be read as a confirmed structural decline because FY26 is a full-year measure while Q1 FY27 is a quarterly run rate.
  • The Annual Report’s quantified volume opportunity is primarily a market projection, rather than a separately stated TANFAC AHF volume-growth target: Indian AHF demand is projected to rise from 110 KT in FY26E to 175 KT by FY31P, implying a 9.7% CAGR. [4]
  • Downstream solar-grade DHF is the stronger growth lever: the Indian market is projected to grow from 19.2 KT to 80 KT over the same period, a 33.0% CAGR, while TANFAC’s solar-grade DHF orders cover close to 85% of annual capacity. [5] [6]

Analyst read: the current 75% rate is directionally consistent with a ramp-up thesis, but it has not yet returned to the 95% FY26 level. Future volume growth is expected to come not only from higher AHF utilization but also from converting AHF internally into solar-grade DHF and HFC-32. Management expects utilization to exceed 90% in the coming year, while acknowledging that captive HFC-32 consumption could temporarily reduce merchant AHF sales. [7]

How has the company managed the volatility in Fluorspar input costs during FY24, and what specific pass-through mechanisms or inventory strategies are reflected in the latest EBITDA margin performance?

Tanfac’s FY24 response was a combination of supplier diversification, currency hedging, selective customer pass-through and process efficiency—not a fully disclosed Fluorspar-indexed pricing model. The result was partial protection: production reached a record level, but lower realisations still compressed profitability. FY24 EBITDA was Rs 77.79 Crores on total revenue of Rs 385.22 Crores, implying a 20.19% margin; Q4 FY24 margin was lower at 17.56%. [8]

What changed in Fluorspar exposure

  • Fluorspar consumption increased from Rs 114.86 Crores in FY23 to Rs 139.51 Crores in FY24, a derived increase of 21.46%. It represented approximately 63.29% of FY24 raw-material consumption of Rs 220.44 Crores. These are consumption values, not unit-price data, so they do not by themselves prove that Fluorspar prices rose by 21.46%. [9]
  • Management reported that FY24 production volumes grew by approximately 20–22% despite lower realisations, with plants operating at optimum capacity. [10]

Pass-through and operating mitigants

  • Customer pass-through: The company stated that raw-material price increases were passed on to customers as part of its geopolitical and cost-risk mitigation approach. [11]
  • Supplier diversification: Tanfac broadened its vendor base beyond China and sought alternative regional sources to reduce supply concentration and cost volatility. [11]
  • FX hedging: Since imported Fluorspar costs are affected by the US dollar, the company used a hedging policy to cover net foreign-exchange exposure and protect margins and cash flows. [11]
  • Lower Fluorspar consumption per unit: Process-improvement initiatives reduced AHF losses and improved scrubber efficiency, which management said led to lower Fluorspar usage. [12]
  • Downstream value addition: The company also pursued alternative downstream products and process improvements to stabilise costs and support competitive pricing. [11]

The FY24 disclosures do not specify a Fluorspar-linked formula, contractual reset frequency, or pass-through lag. Those mechanics could not be confirmed for FY24. Therefore, the 20.19% annual margin should be read as evidence of partial cost recovery plus operating efficiencies, rather than proof of complete input-cost protection. The lower 17.56% Q4 margin and management’s reference to reduced realisations are consistent with some timing or effectiveness gap in recovering cost pressure. [8] [10]

Inventory strategy

  • Management said inventory levels were closely monitored to avoid excessive credit exposure and preserve financial stability. [11]
  • FY24 finished-goods inventory declined from Rs 5.81 Crores at opening to Rs 5.44 Crores at closing; the P&L therefore recorded an inventory increase expense of Rs 0.37 Crores. [9]
  • This points to working-capital discipline rather than a disclosed strategy of building a large finished-goods buffer. Fluorspar raw-material inventory levels, stock days and any price-protection purchases were not separately quantified, so an inventory-led hedge against Fluorspar volatility could not be confirmed.

For later context, the company subsequently described a 30–45-day pass-through lag for sulphur-price increases, but that commentary relates to a later period and to sulphur rather than FY24 Fluorspar; it should not be retrofitted into the FY24 margin explanation. [13]

Based on the latest segment reporting, what is the current revenue split between commodity chemicals and specialty chemicals, and how does this compare to the strategic product mix targets outlined in the company's recent investor disclosures?

The latest investor presentation reports an 80%/20% revenue split, but the extracted segment disclosure does not preserve the labels identifying which share is commodity chemicals and which is specialty chemicals. Therefore, the exact commodity-versus-specialty split could not be confirmed from the cited material. [14]

Analytical read: the company’s disclosures establish a clear directional target—greater specialty and value-added contribution—but not a quantified end-state mix. The Solar Grade DHF platform and planned HFC-32 facility are intended to move the portfolio toward higher-value fluorinated products, while the company describes this as a transition rather than specifying, for example, a 50:50 or 70:30 product mix target. [17] [16]

Accordingly, the defensible comparison is current 80%/20% reported split versus a qualitative specialty-mix expansion strategy; a precise variance to a strategic target cannot be calculated.

ItemLatest disclosed positionStrategic disclosure
Revenue mix80% / 20%; bucket labels not confirmed [14]No explicit numerical commodity-specialty target could be confirmed
Strategic direction—Transition from commodity chemicals toward specialty solutions through forward integration [15]
Specialty expansion—Increase the contribution of value-added products, including Solar Grade DHF and other high-value fluorinated products [16]
Execution vehicles—HFC-32 refrigerant gas, electronic-grade chemicals, specialty fluorochemicals and higher-margin products [17]

Sources

  1. [1]TANFAC Industries Q1 FY27 Earnings Call Transcript: Strong Growth, QIP, HFC-32 Project, and Future Capex Plans — 2026-08-03T09:53:06.873000, p.10
  2. [2]Tanfac Industries Limited Annual Report 2025-26 — 2026-09-01T17:18:54.590000, p.4
  3. [3]Tanfac Industries Q1 FY27 Investor Presentation Highlights — 2026-07-24T15:41:54.193000, p.20
  4. [4]Tanfac Industries Limited Annual Report 2025-26 — 2026-09-01T17:18:54.590000, p.22
  5. [5]Tanfac Industries Limited Annual Report 2025-26 — 2026-09-01T17:18:54.590000, p.16
  6. [6]Tanfac Industries Limited Annual Report 2025-26 — 2026-09-01T17:18:54.590000, p.13
  7. [7]TANFAC Industries Q1 FY27 Earnings Call Transcript: Strong Growth, QIP, HFC-32 Project, and Future Capex Plans — 2026-08-03T09:53:06.873000, p.15
  8. [8]Record FY25 Results for Tanfac Industries Driven by Successful HF Capacity Expansion — 2025-04-28T12:46:06.173000, p.2
  9. [9]Tanfac Industries Limited FY24 Annual Report Submission: Record Production, Zero Debt, and ₹102 Cr AHF Capacity Expansion. — 2024-09-04T13:27:55.123000, p.139
  10. [10]Tanfac Industries Limited FY24 Annual Report Submission: Record Production, Zero Debt, and ₹102 Cr AHF Capacity Expansion. — 2024-09-04T13:27:55.123000, p.9
  11. [11]Tanfac Industries Limited FY24 Annual Report Submission: Record Production, Zero Debt, and ₹102 Cr AHF Capacity Expansion. — 2024-09-04T13:27:55.123000, p.13
  12. [12]Tanfac Industries Limited FY24 Annual Report Submission: Record Production, Zero Debt, and ₹102 Cr AHF Capacity Expansion. — 2024-09-04T13:27:55.123000, p.40
  13. [13]TANFAC Industries Q1 FY27 Earnings Call Transcript: Strong Growth, QIP, HFC-32 Project, and Future Capex Plans — 2026-08-03T09:53:06.873000, p.7
  14. [14]Tanfac Industries Q1 FY27 Investor Presentation Highlights — 2026-07-24T15:41:54.193000, p.16
  15. [15]Tanfac Industries Q1 FY27 Investor Presentation Highlights — 2026-07-24T15:41:54.193000, p.18
  16. [16]Tanfac Industries Q1 FY27 Investor Presentation Highlights — 2026-07-24T15:41:54.193000, p.21
  17. [17]Tanfac Industries FY26 Annual Results Investor Presentation Highlights Strategic Expansion and New Contracts — 2026-05-07T05:59:46.527000, p.36

Keep digging

With the recent completion of the Anhydrous Hydrofluoric Acid (AHF) capacity expansion, what is the current capacity utilization rate, and how does this align with the volume growth targets disclosed in the latest Annual Report?

Ask Copilot
Logo

Unlock financial AI for your firm